MENU
+Compare
CGEM
Stock ticker: NASDAQ
AS OF
Sep 3, 04:59 PM (EDT)
Price
$7.72
Change
+$0.23 (+3.07%)
Capitalization
442.47M

CGEM Cullinan Therapeutics Forecast, Technical & Fundamental Analysis

Cullinan Therapeutics Inc is a biopharmaceutical company... Show more

CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CGEM with price predictions
Sep 02, 2025

Aroon Indicator for CGEM shows an upward move is likely

CGEM's Aroon Indicator triggered a bullish signal on August 06, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 108 similar instances where the Aroon Indicator showed a similar pattern. In of the 108 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CGEM advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

CGEM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CGEM as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CGEM turned negative on September 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

CGEM moved below its 50-day moving average on August 28, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.899) is normal, around the industry mean (19.852). P/E Ratio (0.000) is within average values for comparable stocks, (51.814). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.136). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.082).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CGEM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGEM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CGEM is expected to report earnings to fall 11.83% to -94 cents per share on November 06

Cullinan Therapeutics CGEM Stock Earnings Reports
Q3'25
Est.
$-0.94
Q2'25
Missed
by $0.25
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.10
The last earnings report on August 07 showed earnings per share of -107 cents, missing the estimate of -81 cents. With 191.41K shares outstanding, the current market capitalization sits at 442.47M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
85
Web
https://www.cullinanoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ODIYX129.00-0.73
-0.56%
Invesco Discovery Y
PRPCX4.86-0.04
-0.82%
PGIM Jennison Energy Infrastructure C
ITRGX68.71-0.59
-0.85%
VY® T. Rowe Price Growth Equity S2
RYCEX91.33-1.33
-1.44%
Rydex Europe 1.25x Strategy C
CREEX9.60-0.16
-1.64%
Columbia Real Estate Equity Inst

CGEM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-0.66%
IDYA - CGEM
53%
Loosely correlated
+3.79%
BDTX - CGEM
49%
Loosely correlated
+1.82%
ATXS - CGEM
48%
Loosely correlated
+6.63%
TRDA - CGEM
48%
Loosely correlated
-1.65%
DNLI - CGEM
47%
Loosely correlated
+1.18%
More